Inomata Mitsushi, Hayashi Masami, Ito Yoshimasa, Matsubara Yuko, Takehana Makoto, Kawashima Seiichi, Shumiya Seigo
Department of Protein Biochemistry, Tokyo Metropolitan Institute of Gerontology, Tokyo, Itabashi-ku, Japan.
Curr Eye Res. 2002 Oct;25(4):207-13. doi: 10.1076/ceyr.25.4.207.13486.
It is well known that m-calpain, a ubiquitous calpain, is involved in cataract formation in rodent lens. Involvement of Lp82, a lens-specific calpain, in the cataract formation is also suggested. However, the exact relationship between Lp82-mediated proteolysis and lens opacification has not yet been established. We therefore compared Lp82- and m-calpain-mediated proteolyses of alphaA-crystallin during cataractogenesis to clarify whether Lp82 is involved in cataract formation.
In order to analyze the Lp82- and m-calpain-mediated proteolyses, we developed antibodies exclusively specific to the proteolytic products of alphaA-crystallin produced by Lp82 and m-calpain actions, respectively. The proteolytic profiles of alphaA-crystallin by Lp82 and m-calpain during cataractogenesis in SCR lenses were analyzed by Western blotting and immunohistochemical staining.
While m-calpain-mediated proteolysis was detected predominantly in cataractous lenses, Lp82-mediated proteolysis was detected not only in cataractous but in normal lenses. The m-calpain-mediated proteolysis was observed in restricted areas developing and destined to develop opacification, i.e., the nuclear and perinuclear regions of lens. On the other hand, Lp82-mediated proteolysis was observed not only in the same regions but also in the cortical region where opacity does not develop. Unlike m-calpain-mediated proteolysis, Lp82-mediated proteolysis was not inhibited by the oral administration of aminoguanidine (AG), which acts to prevent lens opacification.
From these results, it is shown that there is no direct contribution of Lp82-mediated proteolysis to cataract formation in SCR. Rather, Lp82 may function in fiber cell development and/or fiber cell remodeling during lens maturation under physiological conditions, since Lp82-mediated proteolysis occurs in the cortical region of normal lens.
众所周知,m-钙蛋白酶是一种普遍存在的钙蛋白酶,参与啮齿动物晶状体白内障的形成。也有人提出晶状体特异性钙蛋白酶Lp82参与白内障的形成。然而,Lp82介导的蛋白水解与晶状体混浊之间的确切关系尚未确立。因此,我们比较了白内障形成过程中Lp82和m-钙蛋白酶介导的αA-晶状体蛋白的蛋白水解作用,以阐明Lp82是否参与白内障的形成。
为了分析Lp82和m-钙蛋白酶介导的蛋白水解作用,我们分别开发了对Lp82和m-钙蛋白酶作用产生的αA-晶状体蛋白水解产物具有特异性的抗体。通过蛋白质印迹法和免疫组织化学染色分析了SCR晶状体白内障形成过程中Lp82和m-钙蛋白酶对αA-晶状体蛋白的蛋白水解谱。
虽然m-钙蛋白酶介导的蛋白水解主要在白内障晶状体中检测到,但Lp82介导的蛋白水解不仅在白内障晶状体中检测到,在正常晶状体中也能检测到。m-钙蛋白酶介导的蛋白水解在晶状体中正在形成和注定会形成混浊的特定区域观察到,即晶状体的核区和核周区。另一方面,Lp82介导的蛋白水解不仅在相同区域观察到,而且在不发生混浊的皮质区域也观察到。与m-钙蛋白酶介导的蛋白水解不同,Lp82介导的蛋白水解不受口服氨基胍(AG)的抑制,AG可防止晶状体混浊。
从这些结果可以看出,Lp82介导的蛋白水解对SCR白内障的形成没有直接作用。相反,Lp82可能在生理条件下晶状体成熟过程中的纤维细胞发育和/或纤维细胞重塑中发挥作用,因为Lp82介导的蛋白水解发生在正常晶状体的皮质区域。